Virtual Medicinal Product (VMP)
-
Granisetron 3.1mg/24hours transdermal patches
Name Details
Current Name
Granisetron 3.1mg/24hours transdermal patches
|
Start Date
06-09-2013
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- patch
- Unit Dose UOM
- patch
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Transdermal
- Form
- Transdermal patch
- Ontology Form/Route
- patch.transdermal
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
A04AA02
BNF |
Current BNF
04060000
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
04060000
|
Start Date
16-06-2014
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
36053011000001101 |
29-10-2018 |
|
442491008 |
12-09-2013 |
28-10-2018 |
VMP Ingredients
VMP ingredients table
Granisetron |
Based on Ingredient Substance |
|
3.1 mg |
24 hour |
Name
Granisetron
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
3.1
Strength and UOM (Dmr)
24.0
Parent Products
-
VTM
Granisetron
-
VMP
(Current) Granisetron 3.1mg/24hours transderma...
Virtual Medicinal Product Pack (VMPP) Information